Blood Biomarkers for Stroke Diagnosis and Management
نویسندگان
چکیده
منابع مشابه
Cardioembolic Stroke Diagnosis Using Blood Biomarkers
Stroke is one of the main causes of death and disability in the world. Cardioembolic etiology accounts for approximately one fifth of all ischemic strokes whereas 25-30% remains undetermined even after an advanced diagnostic workup. Despite there is not any biomarker currently approved to distinguish cardioembolic stroke among other etiologies in clinical practice the use of biomarkers represen...
متن کاملBlood Biomarkers in Cardioembolic Stroke
One promising field in neurovascular diseases investigation is the use of biomarkers to guide stroke etiology diagnosis and classification. Since treatment differs among etiologic subtypes and nowadays many patients receive a diagnosis of undetermined stroke, biomarkers might become an important additional diagnostic tool. In this review we update current knowledge about biomarkers related with...
متن کاملAcute Stroke – Diagnosis and Management
Stroke (noun): a sudden disabling attack... caused by an interruption in the flow of blood to the brain, especially through thrombosis. Stroke is a considerable cause of mortality and morbidity in the UK. The field of stroke medicine has changed considerably in recent years with the development of hyper-acute treatments such as thrombolysis, specialist stroke units and a better understanding of...
متن کاملBlood Pressure Management for Stroke Prevention and in Acute Stroke
Elevated blood pressure (BP) is the leading modifiable risk factor for stroke and the benefit of BP lowering therapy on the stroke risk reduction is well established. The optimal BP target for preventing stroke and other vascular events have been controversial, but the evidences from epidemiological studies and randomized controlled trials (RCTs) support intensive BP lowering for greater vascul...
متن کاملAetiological blood biomarkers of ischaemic stroke.
Each year, over 5 million people die worldwide from stroke, and at least every sixth patient who survives will experience another stroke within five years [1]. We are therefore eager to advance early and rapid diagnosis, prognosis and optimal risk stratification, as well as secondary prevention. In this context, blood biomarkers may improve patient care, as they have already done in other field...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: NeuroMolecular Medicine
سال: 2019
ISSN: 1535-1084,1559-1174
DOI: 10.1007/s12017-019-08530-0